DOI:
10.1055/s-00000146
Diabetes aktuell
LinksClose Window
References
Heller S, Buse J, Fisher M. et al
Insulin degludec, an ultra-longacting basal insulin, versus insulin glargine in basal-bolus treatment with mealtime insulin aspart in type 1 diabetes (BEGIN Basal-Bolus Type 1): a phase 3, randomised, open-label, treat-to-target non-inferiority trial.
Lancet 2012;
379: 1489-1497 doi:10.1016/S0140-6736(12)60204-9
Access:
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.